Immunovant
1 follower
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more
Org chart
Peter Salzmann
Chief Executive Officer
Peter Salzmann
Collapse
Renee Barnett
Chief Financial Officer
William Macias
Chief Medical Officer
Julia G. Butchko
Chief Development Officer
Mark Levine
Chief Legal Officer & Corporate Secretary
Jay S. Stout
Chief Technology Officer
Yan Zheng
VP, Biostatistics & Programming
Jody Roth
VP, Global Regulatory Affairs
Lauren Schrier
VP, Marketing
Lesa Valentine
VP, Quality
Chau Cheng
VP, Investor Relations
Claudia Jacobs
VP, CMC Project Management, Operations & Clinical Supply
Sheetal Patel
VP, Clinical Development
